Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Sales | 674 | 0 | 681 | 674 | 674 |
| Gross Profit | 674 | N/A | 681 | 674 | 674 |
| Operating Expenses | 6,501 | 0 | 2,955 | 4,711 | 3,103 |
| Operating Income | -5,827 | N/A | -2,274 | -4,037 | -2,429 |
| Interest Expense | 12 | 0 | 10 | 0 | 114 |
| Other Income | 269 | 0 | 0 | 349 | 0 |
| Pre-tax Income | -5,570 | 0 | -2,284 | -3,688 | -2,543 |
| Net Income Continuous | -5,570 | N/A | -2,284 | -3,688 | -2,543 |
| Net Income | $-5,570 | $N/A | $-2,284 | $-3,688 | $-2,543 |
| EPS Basic Total Ops | -0.23 | N/A | -0.10 | -0.21 | -0.15 |
| EPS Basic Continuous Ops | -0.23 | N/A | -0.10 | -0.21 | -0.15 |
| EPS Diluted Total Ops | -0.23 | N/A | -0.10 | -0.21 | -0.15 |
| EPS Diluted Continuous Ops | -0.23 | N/A | -0.10 | -0.21 | -0.15 |
| EBITDA(a) | $-5,825 | $N/A | $-2,271 | $-4,035 | $-2,429 |